Table 3.
Common Treatment- Emergent Adverse Events (N=65)
| Variable | Frequency (%) | |
|---|---|---|
| Risperidone (n=32) | Divalproex Sodium (n=33) | |
| Increased appetite | 8 (25.0%) | 10 (31.3%) | 
| Irritable/agitated | 0 (0.0%) | 7 (21.9%) * | 
| Stomach discomfort | 6 (18.8%) | 5 (15.6%) | 
| Sleepiness | 5 (15.6%) | 4 (12.5%) | 
| Fatigue/tiredness | 5 (15.6%) | 4 (12.5%) | 
| Insomnia | 0 (0%) | 4 (12.5%) | 
| Weight gain | 3 (9.4%) | 4 (12.5%) | 
p < .05 for comparison of Divalproex vs. Risperidone